Home ›
Trademark Categories ›
Science & Technology Services ›
2019 ›
GL ›
GLIMMUNE THERAPEUTICS
Trademark search for:
GLIMMUNE THERAPEUTICS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-03-04 — Application filed
2019-03-07 — Application filed
2019-03-22 — Application filed
2019-05-13 — Assigned to examiner
2019-05-20 — Final disposition recorded
2019-05-20 — Final disposition recorded
2019-05-20 — Final disposition recorded
2019-11-13 — Teas/email correspondence entered
2019-11-13 — Office action issued
2019-11-13 — Correspondence received in law office
2019-12-06 — Final disposition recorded
2019-12-06 — Final disposition recorded
2019-12-06 — Final disposition recorded
2020-06-18 — Examiners amendment -written
2020-06-18 — Approved for pub - principal register
2020-06-18 — Examiners amendment e-mailed
2020-06-18 — Notification of examiners amendment e-mailed
2020-06-18 — Examiner's amendment entered
2020-07-01 — Notification of notice of publication e-mailed
2020-07-21 — Published for opposition
2020-07-21 — Official gazette publication confirmation e-mailed
2020-09-15 — Noa e-mailed - sou required from applicant
2021-04-19 — Application abandoned
2021-04-19 — Application abandoned
2021-04-19 — Final status recorded
Owner Information
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited
Correspondent
Maxim Voltchenko KAPLAN BREYER SCHWARZ, LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
